A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast

作者
Mieke Van Bockstal,Marie Colombe Agahozo,Linetta B. Koppert,Carolien H. M. van Deurzen
出处
期刊:International Journal of Cancer [Wiley]
卷期号:146 (5): 1189-1197 被引量:26
标识
DOI:10.1002/ijc.32362
摘要

Ductal carcinoma in situ (DCIS) of the breast is a nonobligate precursor of invasive breast cancer, accounting for 20 % of screen-detected breast cancers. Little is known about the natural progression of DCIS because most patients undergo surgery upon diagnosis. Many DCIS patients are likely being overtreated, as it is believed that only around 50 % of DCIS will progress to invasive carcinoma. Robust prognostic markers for progression to invasive carcinoma are lacking. In the past, studies have investigated women who developed a recurrence after breast-conserving surgery (BCS) and compared them with those who did not. However, where there is no recurrence, the patient has probably been adequately treated. The present narrative review advocates a new research strategy, wherein only those patients with a recurrence are studied. Approximately half of the recurrences are invasive cancers, and half are DCIS. So-called "recurrences" are probably most often the result of residual disease. The new approach allows us to ask: why did some residual DCIS evolve to invasive cancers and others not? This novel strategy compares the group of patients that developed in situ recurrence with the group of patients that developed invasive recurrence after BCS. The differences between these groups could then be used to develop a robust risk stratification tool. This tool should estimate the risk of synchronous and metachronous invasive carcinoma when DCIS is diagnosed in a biopsy. Identification of DCIS patients at low risk for developing invasive carcinoma will individualize future therapy and prevent overtreatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YAMO一完成签到,获得积分10
刚刚
Osborn关注了科研通微信公众号
刚刚
yftan完成签到 ,获得积分10
1秒前
今后的应助被小螃蟹大大王采纳,获得10
3秒前
丁真人发布了新的文献求助10
3秒前
金名水羊完成签到,获得积分10
4秒前
所所的应助被科研通管家采纳,获得10
5秒前
CodeCraft的应助被科研通管家采纳,获得10
5秒前
Crazy_Diamond的应助被科研通管家采纳,获得100
5秒前
郑睿涛发布了新的文献求助10
5秒前
xiaoxuey完成签到,获得积分10
5秒前
科研通AI6.3的应助被科研怪兽采纳,获得10
5秒前
上官若男的应助被科研通管家采纳,获得10
5秒前
甜甜白玉完成签到 ,获得积分10
5秒前
852的应助被科研通管家采纳,获得10
6秒前
CodeCraft的应助被科研通管家采纳,获得10
6秒前
6秒前
pluto的应助被科研通管家采纳,获得10
6秒前
秋风的应助被科研通管家采纳,获得200
6秒前
NexusExplorer的应助被科研通管家采纳,获得10
6秒前
spaghetti完成签到,获得积分10
6秒前
顾矜的应助被科研通管家采纳,获得10
6秒前
6秒前
秋风的应助被科研通管家采纳,获得10
6秒前
李健的应助被科研通管家采纳,获得10
7秒前
wanci的应助被科研通管家采纳,获得10
7秒前
7秒前
ding的应助被科研通管家采纳,获得10
7秒前
Ava的应助被科研通管家采纳,获得10
7秒前
xjh的应助被科研通管家采纳,获得10
7秒前
华仔的应助被科研通管家采纳,获得10
7秒前
7秒前
赘婿的应助被科研通管家采纳,获得10
8秒前
yan发布了新的文献求助10
8秒前
NexusExplorer的应助被科研通管家采纳,获得10
8秒前
CipherSage的应助被科研通管家采纳,获得10
8秒前
小二郎的应助被科研通管家采纳,获得10
8秒前
科研通AI65的应助被科研通管家采纳,获得10
8秒前
Owen的应助被科研通管家采纳,获得10
8秒前
赘婿的应助被科研通管家采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183792
求助须知:如何正确求助?哪些是违规求助? 9573020
关于积分的说明 21828776
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434116
关于科研通互助平台的介绍 2558301
邀请新用户注册赠送积分活动 2480611